Addnode Group AB (publ) (STO:ANOD.B)
Sweden · Delayed Price · Currency is SEK 110.20
-2.20 (-1.96%)
Aug 1, 2025, 5:29 PM CET
Theseus Pharmaceuticals Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 6,261 | 7,757 | 7,412 | 6,225 | 4,077 | 3,807 | Upgrade | |
Revenue Growth (YoY) | -24.57% | 4.66% | 19.07% | 52.69% | 7.09% | 10.86% | Upgrade |
Cost of Revenue | 4,649 | 6,191 | 6,116 | 4,999 | 3,246 | 3,096 | Upgrade |
Gross Profit | 1,612 | 1,566 | 1,296 | 1,226 | 831 | 711 | Upgrade |
Selling, General & Admin | 575 | 568 | 522 | 403 | 281 | 266 | Upgrade |
Operating Expenses | 965 | 958 | 872 | 710 | 523 | 481 | Upgrade |
Operating Income | 647 | 608 | 424 | 516 | 308 | 230 | Upgrade |
Interest Expense | -153 | -158 | -89 | -37 | -16 | -16 | Upgrade |
Interest & Investment Income | 41 | 45 | 32 | 6 | - | 1 | Upgrade |
Currency Exchange Gain (Loss) | 1 | 1 | 2 | -2 | -5 | - | Upgrade |
Other Non Operating Income (Expenses) | -7 | -7 | -9 | -4 | -4 | -3 | Upgrade |
EBT Excluding Unusual Items | 529 | 489 | 360 | 479 | 283 | 212 | Upgrade |
Merger & Restructuring Charges | -13 | -10 | -14 | -13 | -4 | -4 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 24 | 1 | 3 | Upgrade |
Other Unusual Items | 57 | 57 | 16 | 5 | 5 | - | Upgrade |
Pretax Income | 573 | 536 | 362 | 495 | 285 | 211 | Upgrade |
Income Tax Expense | 152 | 134 | 83 | 113 | 62 | 48 | Upgrade |
Earnings From Continuing Operations | 421 | 402 | 279 | 382 | 223 | 163 | Upgrade |
Net Income | 421 | 402 | 279 | 382 | 223 | 163 | Upgrade |
Net Income to Common | 421 | 402 | 279 | 382 | 223 | 163 | Upgrade |
Net Income Growth | 33.65% | 44.09% | -26.96% | 71.30% | 36.81% | 26.36% | Upgrade |
Shares Outstanding (Basic) | 133 | 133 | 133 | 134 | 134 | 134 | Upgrade |
Shares Outstanding (Diluted) | 133 | 133 | 133 | 134 | 134 | 134 | Upgrade |
Shares Change (YoY) | 0.04% | -0.08% | -0.14% | -0.41% | 0.36% | - | Upgrade |
EPS (Basic) | 3.16 | 3.02 | 2.09 | 2.86 | 1.66 | 1.22 | Upgrade |
EPS (Diluted) | 3.16 | 3.02 | 2.09 | 2.86 | 1.66 | 1.22 | Upgrade |
EPS Growth | 33.60% | 44.26% | -26.89% | 72.20% | 36.17% | 26.36% | Upgrade |
Free Cash Flow | 305 | 691 | 459 | 700 | 429 | 571 | Upgrade |
Free Cash Flow Per Share | 2.29 | 5.18 | 3.44 | 5.24 | 3.20 | 4.27 | Upgrade |
Dividend Per Share | 1.150 | 1.150 | 1.000 | 1.000 | 0.750 | 0.625 | Upgrade |
Dividend Growth | 15.00% | 15.00% | - | 33.33% | 20.00% | - | Upgrade |
Gross Margin | 25.75% | 20.19% | 17.48% | 19.70% | 20.38% | 18.68% | Upgrade |
Operating Margin | 10.33% | 7.84% | 5.72% | 8.29% | 7.56% | 6.04% | Upgrade |
Profit Margin | 6.72% | 5.18% | 3.76% | 6.14% | 5.47% | 4.28% | Upgrade |
Free Cash Flow Margin | 4.87% | 8.91% | 6.19% | 11.24% | 10.52% | 15.00% | Upgrade |
EBITDA | 779 | 740 | 539 | 612 | 378 | 294 | Upgrade |
EBITDA Margin | 12.44% | 9.54% | 7.27% | 9.83% | 9.27% | 7.72% | Upgrade |
D&A For EBITDA | 132 | 132 | 115 | 96 | 70 | 64 | Upgrade |
EBIT | 647 | 608 | 424 | 516 | 308 | 230 | Upgrade |
EBIT Margin | 10.33% | 7.84% | 5.72% | 8.29% | 7.56% | 6.04% | Upgrade |
Effective Tax Rate | 26.53% | 25.00% | 22.93% | 22.83% | 21.75% | 22.75% | Upgrade |
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.